4//SEC Filing
Dierks Jeffrey 4
Accession 0001415889-25-006919
CIK 0001802665other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:05 PM ET
Size
11.1 KB
Accession
0001415889-25-006919
Insider Transaction Report
Form 4
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-03$8.22/sh+4,869$40,023→ 4,869 total - Sale
Common Stock
2025-03-03$32.61/sh−4,369$142,474→ 500 total - Sale
Common Stock
2025-03-03$33.23/sh−500$16,615→ 0 total - Exercise/Conversion
Stock Option
2025-03-03−4,869→ 0 totalExercise: $8.22Exp: 2030-03-04→ Common Stock (4,869 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.08 to $32.97. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.14 to $33.39. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock option vests in five equal annual installments beginning on March 1, 2021.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001821102
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:05 PM ET
- Size
- 11.1 KB